Insider Trading June 23, 2026 11:07 AM

Healthcare Realty Trust Executive Offloads Equity Amid Strong Market Performance

SVP and Chief Accounting Officer Amanda Callaway executes transaction as the company navigates recent debt offerings and positive analyst revisions.

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
HR

Amanda L. Callaway, Senior Vice President and Chief Accounting Officer at Healthcare Realty Trust Inc (NYSE:HR), executed a significant equity transaction on June 23, 2026, selling 25,767 shares of the company's common stock. The transaction, valued at approximately $524,873, occurred at prices ranging from $20.32 to $20.45 per share, with a weighted-average sales price of $20.37. Following this divestment, Ms. Callaway retains direct ownership of 109,954 shares. The sale takes place as Healthcare Realty Trust shares trade near their 52-week high of $20.89, reflecting a robust 37% return over the past year. Despite strong recent performance, analysis indicates the stock may be trading at a premium relative to InvestingPro’s Fair Value assessment.

Healthcare Realty Trust Executive Offloads Equity Amid Strong Market Performance
HR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Amanda L. Callaway, Senior Vice President and Chief Accounting Officer at Healthcare Realty Trust Inc (NYSE:HR), executed a significant equity transaction on June 23, 2026, selling 25,767 shares of the company's common stock.
  • The transaction, valued at approximately $524,873, occurred at prices ranging from $20.32 to $20.45 per share, with a weighted-average sales price of $20.37.
  • Following this divestment, Ms. Callaway retains direct ownership of 109,954 shares.

Amanda L. Callaway, Senior Vice President and Chief Accounting Officer at Healthcare Realty Trust Inc (NYSE:HR), executed a significant equity transaction on June 23, 2026, selling 25,767 shares of the company's common stock. The transaction, valued at approximately $524,873, occurred at prices ranging from $20.32 to $20.45 per share, with a weighted-average sales price of $20.37. Following this divestment, Ms. Callaway retains direct ownership of 109,954 shares.

The timing of the sale is notable as Healthcare Realty stock is trading near its 52-week high of $20.89, according to InvestingPro data. The stock has delivered strong returns of 37% over the past year. Analysis suggests the company currently appears overvalued relative to InvestingPro's Fair Value assessment.

In other recent news, Healthcare Realty Trust Incorporated reported significant financial and strategic developments. The company announced a $400 million senior unsecured delayed draw term loan facility, with a maturity date set for May 15, 2029. Additionally, Healthcare Realty Trust priced an offering of $600 million aggregate principal amount of 3.00% exchangeable senior notes due 2032, increasing the offering size from the initially announced $500 million. Cantor Fitzgerald raised its price target for Healthcare Realty Trust to $22, maintaining an Overweight rating, following the company's solid first-quarter 2026 results and an increase in full-year funds from operations guidance to a range of $1.59 to $1.65.

In corporate governance, Healthcare Realty Trust shareholders elected six directors during the annual meeting, with high approval percentages for each. The company also announced plans for a $500 million exchangeable notes offering, with an option for initial purchasers to buy an additional $75 million in notes. These notes are senior, unsecured obligations with interest payable semi-annually and a maturity date of January 15, 2032. These recent developments highlight Healthcare Realty Trust's ongoing financial strategies and corporate governance activities.

Key Points

  • Amanda L. Callaway, Senior Vice President and Chief Accounting Officer at Healthcare Realty Trust Inc (NYSE:HR), executed a significant equity transaction on June 23, 2026, selling 25,767 shares of the company's common stock.
  • The transaction, valued at approximately $524,873, occurred at prices ranging from $20.32 to $20.45 per share, with a weighted-average sales price of $20.37.
  • Following this divestment, Ms. Callaway retains direct ownership of 109,954 shares.

Risks and Uncertainties

  • The stock has delivered strong returns of 37% over the past year. Analysis suggests the company currently appears overvalued relative to InvestingPro's Fair Value assessment.
  • The timing of the sale is notable as Healthcare Realty stock is trading near its 52-week high of $20.89, according to InvestingPro data.
  • The company also announced plans for a $500 million exchangeable notes offering, with an option for initial purchasers to buy an additional $75 million in notes. These notes are senior, unsecured obligations with interest payable semi-annually and a maturity date of January 15, 2032.

Risks

  • The stock has delivered strong returns of 37% over the past year. Analysis suggests the company currently appears overvalued relative to InvestingPro's Fair Value assessment.
  • The timing of the sale is notable as Healthcare Realty stock is trading near its 52-week high of $20.89, according to InvestingPro data.
  • The company also announced plans for a $500 million exchangeable notes offering, with an option for initial purchasers to buy an additional $75 million in notes. These notes are senior, unsecured obligations with interest payable semi-annually and a maturity date of January 15, 2032.

More from Insider Trading

Executive Capital Commitment at Bed Bath & Beyond Aug 6, 2026 EXLService President Vikas Bhalla Executes $384,890 Share Sale Under Pre-Existing Trading Plan Aug 6, 2026 Arcutis Biotherapeutics Executive Divests Shares Amid Strong Financial Backdrop Aug 6, 2026 Executive Capital Deployment and Leadership Restructuring at Hanover Bancorp Aug 3, 2026 Adaptive Biotechnologies Executive Liquidates Shares as Volume Metrics Diverge From Profitability Aug 3, 2026